(Q47655490)

English

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model

scientific article published in April 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

0 references

0 references

0 references

experimental autoimmune encephalomyelitis

0 references

cannabinoid receptor

0 references

author name string

Xiang Ni

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

Ellen B Geller

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

Michael J Eppihimer

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

Toby K Eisenstein

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

Martin W Adler

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

Ronald F Tuma

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

158-164

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

Management of multiple sclerosis: current trials and future options

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Mechanisms of inflammation and leukocyte activation

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Endothelial cell adhesion molecules in inflammation and postischemic reperfusion injury

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Cannabinoids and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

A chronic model to simultaneously measure intracranial pressure, cerebral blood flow, and study the pial microvasculature

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Pathogenesis of multiple sclerosis: an update on immunology

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Molecular pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Cannabinoid receptors and the regulation of immune response

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Cannabinoid receptors and immunity

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Production and physiological actions of anandamide in the vasculature of the rat kidney.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Nitric oxide: an endogenous modulator of leukocyte adhesion

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1009OA

21 January 2018

Identifiers

10.1191/1352458504MS1009OA

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/15124761

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47655490&oldid=2164210752"